Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 years or older) with Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Study identifier:BY9010/M1-490

ClinicalTrials.gov identifier:NCT00806754

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 years or older) with Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy

Medical condition

Rhinitis, Allergic, perennial

Phase

Phase 4

Healthy volunteers

No

Study drug

Ciclesonide nasal spray + placebo Azelastine, Ciclesonide nasal spray + Azelastine

Sex

All

Actual Enrollment

340

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Nov 2006
Primary Completion Date: 01 May 2007
Study Completion Date: 01 Aug 2007

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria